Romiset 125mcg Injection
By Romiset
Rx
1 Injection in a Vial

Composition
Romiplostim(125mcg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
September, 2025

liver
Limited information is available regarding the use of Romiset 125mcg Injection in patients with liver disease. It is advisable to consult your doctor for personalized guidance and to assess the potential risks and benefits of using this medication in such cases. Taking into consideration the lack of specific data on the effects of Romiset 125mcg Injection on the liver, healthcare provider guidance is crucial to ensure the safe and appropriate use of this medication in individuals with liver issues.

kidney
Limited information is available regarding the use of Romiset 125mcg Injection in individuals with kidney disease. It is advised to consult your doctor before using this medication.

alcohol
Consult your doctor before consuming alcohol with Romiset 125mcg Injection.

driving
When using Romiset 125mcg Injection, be cautious as it may cause dizziness, affecting your ability to drive. If you feel dizzy, avoid driving or using machinery.

pregnancy
Romiset 125mcg Injection may not be safe to use during pregnancy. Limited human studies show risks, and animal studies suggest harm to the developing baby. Your doctor will consider benefits and risks before prescribing. Consult your doctor.

breastfeeding
Romiset 125mcg Injection is considered safe during breastfeeding based on limited human data indicating low risk to the baby.
Habit Forming | No |
Chemical Class | Carboxylic acid and derivatives |
Therapeutic Class | - |
Action Class | Thrombopoietin agonist |
₹2995
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025